lifestyle.cleanweb.co

Author: STEALTH BIOTHERAPEUTICS INC.

Stealth BioTherapeutics Appoints David A. Brown, Ph.D., as Chief Scientific Officer to Advance the Company’s Pioneering Work in Mitochondrial Medicine

May 2, 2026
Stealth BioTherapeutics Announces MRC Business Engagement Fund Grant to Advance Mitochondrial Disease Research

April 30, 2026
Stealth BioTherapeutics Provides Commercial and R&D Pipeline Update and Outlines 2026 Strategic Priorities

January 6, 2026